Peripheral Vascular Devices Market
Peripheral Vascular Devices Market By Product Type (Percutaneous Transluminal Angioplasty Balloon Catheters [Normal, Drug-Eluting, Cutting, And Scoring], Angioplasty Stents [Drug-Eluting, Bare-Metal, and Expandable], Plaque Modification Devices [Arthrectomy Devices and Thrombectomy Devices], Hemodynamic Flow Alteration Devices [Embolic Protection Devices and Chronic Total Occlusion Devices], Inferior Venacava Filters [Retrieavable And Permanent], and Others) and By End User (Hospitals, Ambulatory Surgical Centers, And Others), By Geography is expected to grow at a steady CAGR Forecast till 2026 owing to rising technological advancement and increasing prevalence of cardiovascular and Peripheral Vascular Diseases
Global Peripheral Vascular Devices Market
Global Peripheral Vascular Devices Market was valued at USD 8.96 billion in 2020, growing at a CAGR of 7.85% during the forecast period from 2021 to 2026, to reach USD 13.42 billion by 2026. The demand for peripheral vascular devices is primarily being boosted by the rapid growth in the prevalence of cardiovascular diseases and peripheral vascular diseases, the approval of new and advanced products, and the rising incidence of lifestyle disorders such as diabetes and hypertension. Furthermore, the increase in the geriatric population is also likely to contribute to the peripheral vascular devices market growth.
Download free sample copy- https://www.delveinsight.com/sample-request/peripheral-vascular-devices-market-market
List of Peripheral Vascular Devices Market Companies involved in the report
- Medtronic
- Boston Scientific Corporation
- B. Braun Melsungen AG
- Braile Biomedica
- JOTEC GmbH
- Edwards Life Sciences Corporation
- LeMaitre Vascular, Inc.
- W. L. Gore & Associates, Inc
- Abbott, Cardiovascular Systems, Inc.
- AngioDynamics Inc
- Control Medical Technology, LLC
- Walk Vascular, LLC
- Transit Scientific
- Conic Vascular and others
Peripheral Vascular Devices Market Dynamics
According to the World Health Organization data, cardiovascular diseases (CVDs) are the leading cause of death across the globe, wherein these diseases affect an estimated number of 17.9 million lives each year. CVDs are referred to as a group of disorders that specifically affect the heart and blood vessels. Some of these include coronary heart disease, rheumatic heart disease, cerebrovascular disease, and other indications. Furthermore, the same source by the WHO presented that over four out of five CVD deaths mention strokes and heart attacks as the main cause, and about one-third of people below 70 years of age fall victim to these CVD-related deaths. It has been observed that low- and middle-income countries account for more than three-quarters of CVD deaths.
Peripheral Vascular Devices Market Segment Analysis
Peripheral Vascular Devices by Product Type (PTA Balloon Catheters [Normal, Drug-Eluting, Cutting, And Scoring], Angioplasty Stents [Drug-Eluting, Bare-Metal, And Expandable], Plaque Modification Devices [Arthrectomy Devices And Thrombectomy Devices], Hemodynamic Flow Alteration Devices [Embolic Protection Devices And Chronic Total Occlusion Devices], Inferior Venacava Filters [Retrievable And Permanent], And Others), Peripheral Vascular Devices by End User (Hospitals, Ambulatory Surgical Centers, And Others), and Peripheral Vascular Devices by Geography (North America, Europe, Asia-Pacific, and Rest of the World).
Recent Developmental Activities in Peripheral Vascular Devices Market:
- In June 2021, AngioDynamics Inc received the 510k clearance from the US Food and Drug Administration for their AlphaVac Mechanical Thrombectomy System. The device is an off-circuit, multi-purpose mechanical aspiration thrombectomy system which is deployed in the non-surgical removal of emboli or thrombi from the vasculature.
- In May 2021, Transit Scientific received the CE Mark clearance in the European Union for the XO Score® Scoring Sheath Platform. This device facilitates in the dilation of stenotic material in the peripheral vasculature including infrapopliteal, popliteal, and native or synthetic arteriovenous dialysis fistulae.
- In January 2021, Cardiovascular Systems, Inc. received the CE Mark for Diamondback 360® Coronary Orbital Atherectomy System. It combines differential sanding and pulsatile forces with the aim to treat all calcium modalities, including eccentric (irregular), nodular, and concentric (ring-shaped).
Download free sample copy- https://www.delveinsight.com/sample-request/peripheral-vascular-devices-market-market
Table of content
1. Peripheral Vascular Devices Market Report Introduction
2. Peripheral Vascular Devices Market Executive Summary
3. Regulatory and Patent Analysis
4. Peripheral Vascular Devices Market Key Factors Analysis
5. Peripheral Vascular Devices Market Porter’s Five Forces Analysis
6. COVID-19 Impact Analysis on Peripheral Vascular Devices Market
7. Peripheral Vascular Devices Market Layout
8. Peripheral Vascular Devices Global Company Share Analysis – Key 3-5 Companies
9. Peripheral Vascular Devices Company and Product Profiles
10. Project Approach
11. KOL Views
12. DelveInsight Capabilities
13. Disclaimer
14. About DelveInsight
Frequently Asked Questions for Peripheral Vascular Devices Market
- What is a Peripheral Vascular Device?
- What is the market for Global Peripheral Vascular Devices?
- What are the drivers for Global Peripheral Vascular Devices Market?
- What are the key players operating in the Global Peripheral Vascular Devices Market?
- What region has the highest share in the Peripheral Vascular Devices market?
Contact Us
Yash
info@delveinsight.com
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email:Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
